07:00 , Mar 18, 2013 |  BioCentury  |  Strategy

Japan's biggest biotech

Japanese pharmaceutical companies have historically been thought of as stodgy, insular and opaque, but that is changing fast. One year into the job, Kyowa Hakko Kirin Co. Ltd. 's CEO is building his company along...
07:00 , Jun 6, 2011 |  BC Week In Review  |  Company News

ImmunoCellular, Kyowa Hakko Kirin deal

ImmunoCellular and Kyowa's BioWa Inc. subsidiary launched newco Caerus Discovery LLC (Manassas, Va.) to discover and develop therapeutic targets and biomarkers. Caerus uses combinations of adjuvants, high zone tolerance and subtractive immunization to identify targets...